{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:56:12Z","timestamp":1793822172597,"version":"4.6.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Bayer Schering Pharma AG"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.ejogrb.2010.12.027","type":"journal-article","created":{"date-parts":[[2011,2,3]],"date-time":"2011-02-03T04:15:38Z","timestamp":1296706538000},"page":"171-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 \u03bcg plus drospirenone 3 mg administered in a 24\/4 regimen: a pooled analysis"],"prefix":"10.1016","volume":"155","author":[{"given":"William","family":"Koltun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Marr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejogrb.2010.12.027_bib0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2133.1999.02768.x","article-title":"The quality of life in acne: a comparison with general medical conditions using generic questionnaires","volume":"140","author":"Mallon","year":"1999","journal-title":"Br J Dermatol"},{"issue":"15","key":"10.1016\/j.ejogrb.2010.12.027_bib0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2165\/00003495-200363150-00005","article-title":"Current concepts of the pathogenesis of acne: implications for drug treatment","volume":"63","author":"Gollnick","year":"2003","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.ejogrb.2010.12.027_bib0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00403804","article-title":"Estrogen and androgen receptors in patients with acne vulgaris (author's transl)","volume":"268","author":"Schmidt","year":"1980","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"10.1016\/j.ejogrb.2010.12.027_bib0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000298915","article-title":"Androgen receptor in hirsutism and acne","volume":"22","author":"Schmidt","year":"1986","journal-title":"Gynecol Obstet Invest"},{"issue":"4 Suppl.","key":"10.1016\/j.ejogrb.2010.12.027_bib0025","first-page":"2","article-title":"The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea","volume":"69","author":"van Vloten","year":"2002","journal-title":"Cutis"},{"issue":"1A","key":"10.1016\/j.ejogrb.2010.12.027_bib0030","doi-asserted-by":"crossref","first-page":"104S","DOI":"10.1016\/S0002-9343(99)80067-9","article-title":"The androgenicity of progestins","volume":"98","author":"Darney","year":"1995","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.ejogrb.2010.12.027_bib0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1701-2163(16)31058-1","article-title":"Oral contraceptives as anti-androgenic treatment of acne","volume":"24","author":"Lemay","year":"2002","journal-title":"J Obstet Gynaecol Can"},{"issue":"2","key":"10.1016\/j.ejogrb.2010.12.027_bib0040","first-page":"30","article-title":"Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment","volume":"74","author":"Thorneycroft","year":"2004","journal-title":"Cutis"},{"issue":"Suppl. 3","key":"10.1016\/j.ejogrb.2010.12.027_bib0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14730782.2000.12288987","article-title":"The contraceptive profile of a new oral contraceptive with antimineralocorticoid and antiandrogenic effects","volume":"5","author":"Foidart","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"10.1016\/j.ejogrb.2010.12.027_bib0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.ejogrb.2010.12.027_bib0055","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/13625180008500407","article-title":"A 1-year pharmacokinetic investigation of a novel oral contraceptive containing drospirenone in healthy female volunteers","volume":"5","author":"Blode","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"4","key":"10.1016\/j.ejogrb.2010.12.027_bib0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.contraception.2007.11.003","article-title":"Efficacy and safety of 3mg drospirenone\/20mcg ethinylestradiol oral contraceptive administered in 24\/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial","volume":"77","author":"Koltun","year":"2008","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.ejogrb.2010.12.027_bib0065","first-page":"50","article-title":"A combined oral contraceptive containing 3-mg drospirenone\/20-microg ethinyl estradiol in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled study evaluating lesion counts and participant self-assessment","volume":"82","author":"Lucky","year":"2008","journal-title":"Cutis"},{"issue":"4","key":"10.1016\/j.ejogrb.2010.12.027_bib0070","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/AOG.0b013e318187e1c5","article-title":"Treatment of acne using a 3-milligram drospirenone\/20-microgram ethinyl estradiol oral contraceptive administered in a 24\/4 regimen: a randomized controlled trial","volume":"112","author":"Maloney","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2010.12.027_bib0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2008.02.019","article-title":"Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24\/4 regimen","volume":"78","author":"Klipping","year":"2008","journal-title":"Contraception"},{"issue":"5 Pt 1","key":"10.1016\/j.ejogrb.2010.12.027_bib0080","first-page":"54","article-title":"Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris","volume":"37","author":"Lucky","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.ejogrb.2010.12.027_bib0085","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0029-7844(97)00059-8","article-title":"Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial","volume":"89","author":"Redmond","year":"1997","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2010.12.027_bib0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.contraception.2004.05.013","article-title":"Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3mg drospirenone","volume":"70","author":"Bachmann","year":"2004","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.ejogrb.2010.12.027_bib0095","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2004.12.005","article-title":"Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism","volume":"71","author":"Klipping","year":"2005","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.ejogrb.2010.12.027_bib0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.contraception.2005.08.021","article-title":"Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation","volume":"72","author":"Pearlstein","year":"2005","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.ejogrb.2010.12.027_bib0105","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstet Gynecol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121151100008X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121151100008X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:23:25Z","timestamp":1759555405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030121151100008X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S030121151100008X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2010.12.027","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20\u03bcg plus drospirenone 3mg administered in a 24\/4 regimen: a pooled analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2010.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}